Skip Nav Destination
Article navigation
Articles|
January 2012
SEE Question
ASA Newsletter January 2012, Vol. 76, 35.
Citation
SEE Question. ASA Newsletter 2012; 76:35
Download citation file:
Sign in
ASA members enjoy complimentary access to ASA publications, as well as a variety of educational resources. Join today!
ASA Members and Registered Users
Sign InInstitutional Administrators
Admin PortalPay-Per-View Access
$20.00
Advertisement
1
Views
0
Citations
Email alerts
Related Articles
Evidence against Trigger Point Injection Technique for the Treatment of Cervicothoracic Myofascial Pain with Botulinum Toxin Type A
Anesthesiology (August 2005)
Piriformis Syndrome: Anatomic Considerations, a New Injection Technique, and a Review of the Literature
Anesthesiology (June 2003)
Does Botulinum Toxin Have a Role in the Management of Myofascial Pain?
Anesthesiology (August 2005)
Management of Post-thoracotomy Pseudoangina and Myofascial Pain with Botulinum Toxin
Anesthesiology (September 1999)
Long-term Effects of Botulinum Toxin on Neuromuscular Function
Anesthesiology (June 2007)
Advertisement